Free tool
Diagnostics stocks
We cover 5 companies grouped under the Diagnostics theme. The median market value in the group is $26.99B. Across the group, the median move over the past trading day is +1.07%. Price change over the past year runs from +3.6% to +142.8% across the middle 80 percent of the group, with a median of +38.7%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.24% | Nov 5, 2026 |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +23.25% | Nov 3, 2026 |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.70% | Oct 20, 2026 |
| GH | Guardant Health, Inc. | $21.90B | Large cap | +166.52% | Oct 28, 2026 |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −9.45% | Nov 3, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.